Effects of pregnancy on obesity-induced inflammation in a mouse model of fetal programming

International Journal of Obesity

Volumn 38, Issue 10, 2014, Pages 1282-1289

  Ingvorsen, C ^a,b   Thysen, A H ^a   Fernandez Twinn, D ^c   Nordby, P ^a   Nielsen, K F ^a   Ozanne, S E ^c   Brix, S ^a   Hellgren, L I ^a,b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Center for Fetal Programming   (Denmark)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Fetal programming; Inflammation; Macrophage; Pregnancy

Indexed keywords

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CELL INFILTRATION; CONCEPTION; CONTROLLED STUDY; DIET; EXPERIMENTAL MODEL; FEMALE; INFLAMMATION; INSULIN SENSITIVITY; LIVER; MACROPHAGE; MATERNAL OBESITY; MONOCYTE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; DISEASE MODEL; FETUS DEVELOPMENT; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLIC SYNDROME X; METABOLISM; OBESITY; PATHOLOGY; PRENATAL EXPOSURE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETAL DEVELOPMENT; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; WEIGHT GAIN;

EID: 84964313366     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.69     Document Type: Article

References (46)

1. Samuelsson AM, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EH et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension 2008; 51: 383-392.
2. Oben JA, Mouralidarane A, Samuelsson AM, Matthews PJ, Morgan ML, McKee C et al. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol 2010; 52: 913-920.
3. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111-2117.
4. Hodyl NA, Krivanek KM, Lawrence E, Clifton VL, Hodgson DM. Prenatal exposure to a pro-inflammatory stimulus causes delays in the development of the innate immune response to LPS in the offspring. J Neuroimmunol 2007; 190: 61-71.
5. Lasala N, Zhou H. Effects of maternal exposure to LPS on the inflammatory response in the offspring. J Neuroimmunol 2007; 189: 95-101.
6. Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A et al. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab 2001; 281: E326-E334.
7. Beloosesky R, Maravi N, Weiner Z, Khatib N, Awad N, Boles J et al. Maternal lipopolysaccharide-induced inflammation during pregnancy programs impaired offspring innate immune responses. Am J Obstet Gynecol 2010; 203: 185.
8. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47: 87-103.
9. Saito S. Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol 2001; 52: 15-33.
10. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
11. Deopurkar R, Ghanim H, Friedman J, Abuaysheh S, Sia CL, Mohanty P et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 2010; 33: 991-997.
12. Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM et al. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009; 32: 2281-2287.
13. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008; 87: 1219-1223.
14. Talukdar S, Oh da Y, Bandyopadhyay G, Li D, Xu J, McNelis J et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 2012; 18: 1407-1412.
15. Elgazar-Carmon V, Rudich A, Hadad N, Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 2008; 49: 1894-1903.
16. Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009; 15: 940-945.
17. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
18. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulaton of sphingolipid metabolism. Endocr Rev 2008; 29: 381-402.
19. Virtue S, Vidal-Puig A Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim Biophys Acta 2010; 1801: 338-349.
20. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007; 5: 167-179.
21. Kolak M, Westerbacka J, Velagapudi VR, Wagsater D, Yetukuri L, Makkonen J et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007; 56: 1960-1968.
22. Park TS, Goldberg IJ. Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure. Heart Fail Clin 2012; 8: 633-641.
23. Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C et al. Role of leptin in the activation of immune cells. Mediators Inflamm 2010; 2010: 568343.
24. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184.
25. Oben JA, Mouralidarane A, Samuelsson A-M, Matthews PJ, Morgan ML, McKee C et al. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol 2010; 52: 913-920.
26. Samuelsson AM, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen E et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance-a novel murine model of developmental programming. Hypertension 2008; 51: 383-392.
27. Pedersen MH, Lauritzen L, Hellgren LI. Fish oil combined with short chain fatty acids synergistically prevent tissue accumulation of free fatty acids during weight loss in obese mice. Br J Nutr 2011; 106: 1449-1456.
28. Sasaki K, Iwatsuki H. Origin and fate of the central macrophages of erythroblastic islands in the fetal and neonatal mouse liver. Microsc Res Techniq 1997; 39: 398-405.
29. Anderson MJ. Permutation tests for univariate or multivariate analysis of variance and regression. Can J Fish Aquat Sci 2001; 58: 626-639.
30. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
31. Fraker DL, Stovroff MC, Merino MJ, Norton JA. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 1988; 168: 95-105.
32. Fernandez-Twinn DS, Blackmore HL, Siggens L, Giussani DA, Cross CM, Foo R et al. The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation. Endocrinology 2012; 153: 5961-5971.
33. Nixon GF. Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 2009; 158: 982-993.
34. Jiao P, Chen Q, Shah S, Du J, Tao B, Tzameli I et al. Obesity-related upregulation of monocyte chemotactic factors in adipocytes involvement of nuclear factor-kappa B and c-Jun NH2-terminal kinase pathways. Diabetes 2009; 58: 104-115.
35. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116: 115-124.
36. Medvedev AE, Vogel SN. Overexpression of CD14, TLR4, and MD-2 in HEK 293T cells does not prevent induction of in vitro endotoxin tolerance. J Endotoxin Res 2003; 9: 60-64.
37. Hauguel-de Mouzon, S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta 2006; 27: 794-798.
38. Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, Powell TL. Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta 2011; 32: 121-127.
39. Luppi P. How immune mechanisms are affected by pregnancy. Vaccine 2003; 21: 3352-3357.
40. Pazos M, Sperling RS, Moran TM, Kraus TA. The influence of pregnancy on systemic immunity. Immunol Res 2012; 54: 254-261.
41. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008; 29: 274-281.
42. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav 2012; 62: 263-271.
43. Zhu MJ, Ma Y, Long NM, Du M, Ford SP. Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe. Am J Physiol-Reg I 2010; 299: R1224-R1231.
44. McCurdy CE, Bishop JM, Williams SM, Grayson BE, Smith MS, Friedman JE et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009; 119: 323-335.
45. Dahlgren J. Pregnancy and insulin resistance. Metab Syndr Relat Disord 2006; 4: 149-152.
46. Shelley P, Martin-Gronert MS, Rowlerson A, Poston L, Heales SJR, Hargreaves IP et al. Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice. Am J Physiol-Regul Integr Comp Physiol 2009; 297: R675-R681.